Aggressive MLL gene rearranged CD7+ CD56+ myeloid/natural killer cell precursor acute leukaemia with extramedullary relapse in the uterus and breast

被引：2
|
作者：
Soon, Gwyneth [1 ]
Lee, Shir Ying [2 ]
Wang, Shi [1 ]
机构：
[1] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Pathol, Singapore, Singapore
[2] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Haematol Oncol, Singapore, Singapore
来源：
PATHOLOGY | 2015年 / 47卷 / 06期
关键词：
MYELOID SARCOMA;
D O I：
10.1097/PAT.0000000000000310
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：588 / 591
页数：4
相关论文
共 27 条
  • [1] CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside
    Handa, H
    Motohashi, S
    Isozumi, K
    Komatsumoto, S
    Nara, M
    ACTA HAEMATOLOGICA, 2002, 108 (01) : 47 - 52
  • [2] Importance of T-cell receptor δ-chain gene analysis on CD7+ and CD56+ myeloid natural killer cell precursor acute leukemia
    Kimura, N
    Yoshida, T
    Nagano, M
    Tamura, K
    BLOOD, 1998, 91 (07) : 2622 - 2623
  • [3] Importance of T-cell receptor δ-chain gene analysis on CD7+ and CD56+ myeloid natural killer cell precursor acute leukemia -: Response
    Suzuki, R
    Seto, M
    Morishima, Y
    Nakamura, S
    BLOOD, 1998, 91 (07) : 2623 - 2624
  • [4] Five children and seven adults with CD7+ CD56+ CD3- acute natural killer cell leukemia
    Spahn, G
    Sperling, C
    Büchner, T
    Creutzig, U
    Schlegelberger, B
    Harbott, J
    Döhner, H
    Dörken, B
    Ludwig, WD
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 114 - 114
  • [5] CD7 and CD56 positive myeloid/natural killer cell precursor acute leukemia.
    Suzuki, R
    Seto, M
    Taji, H
    Yatabe, Y
    Kagami, Y
    Ogura, M
    Ueda, R
    Morishima, Y
    Nakamura, S
    BLOOD, 1997, 90 (10) : 2219 - 2219
  • [6] Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia
    Chen, VMY
    McIlroy, K
    Loui, JPY
    Fay, K
    Ward, C
    PATHOLOGY, 2003, 35 (04) : 325 - 329
  • [7] The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0
    Ritsuro Suzuki
    Shigeki Ohtake
    Jin Takeuchi
    Masami Nagai
    Yoshihisa Kodera
    Motohiro Hamaguchi
    Shuichi Miyawaki
    Takahiro Karasuno
    Shigetaka Shimodaira
    Ryuzo Ohno
    Shigeo Nakamura
    Tomoki Naoe
    International Journal of Hematology, 2010, 91 : 303 - 309
  • [8] The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0
    Suzuki, Ritsuro
    Ohtake, Shigeki
    Takeuchi, Jin
    Nagai, Masami
    Kodera, Yoshihisa
    Hamaguchi, Motohiro
    Miyawaki, Shuichi
    Karasuno, Takahiro
    Shimodaira, Shigetaka
    Ohno, Ryuzo
    Nakamura, Shigeo
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 303 - 309
  • [9] CD7(+) and CD56(+) myeloid natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity
    Suzuki, R
    Yamamoto, K
    Seto, M
    Kagami, Y
    Ogura, M
    Yatabe, Y
    Suchi, T
    Kodera, Y
    Morishima, Y
    Takahashi, T
    Saito, H
    Ueda, R
    Nakamura, S
    BLOOD, 1997, 90 (06) : 2417 - 2428
  • [10] CD7+CD56+myeloid/natural killer-cell precursor acute leukemias lack TCRδ-gene rearrangement and expression of natural killer-cell inhibitory receptors (NKIR).
    Spahn, G
    Schmidt, CA
    Wuchter, C
    Harbott, J
    Schlegelberger, B
    Moretta, A
    Dörken, B
    Ludwig, WD
    BLOOD, 2000, 96 (11) : 198B - 198B
123